Cara Therapeutics, Inc.

Historical 13F Holders

Symbol
CARA
CUSIP
140755109
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 140755109 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vifor (International) Ltd 13D/A
Amended under CUSIP 140755307 on 4/16/2025
13.5% 12/18/2024
Event 12/17/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q4 1 20.2 k $7.16k
2024 Q3 70 13.5 M $4.17M
2024 Q2 83 17.7 M $4.56M
2024 Q1 102 23.6 M $21.7M
2023 Q4 113 24.4 M $18.1M
2023 Q3 124 27.1 M $45.6M
2023 Q2 138 29.4 M $83.3M
2023 Q1 163 33.9 M $166M
2022 Q4 165 34.0 M $365M
2022 Q3 166 34.6 M $324M
2022 Q2 183 34.8 M $318M
2022 Q1 187 31.7 M $387M
2021 Q4 189 30.3 M $369M
2021 Q3 175 29.6 M $457M
2021 Q2 177 31.1 M $444M
2021 Q1 172 32.4 M $704M
2020 Q4 157 32.7 M $494M
2020 Q3 162 33.4 M $425M
2020 Q2 149 32.7 M $559M
2020 Q1 139 32.2 M $425M
2019 Q4 156 31.4 M $505M
2019 Q3 151 30.5 M $558M
2019 Q2 130 26.4 M $567M
2019 Q1 140 22.3 M $438M
2018 Q4 138 24.3 M $315M
2018 Q3 151 23.6 M $566M
2018 Q2 136 19.5 M $368M
2018 Q1 122 17.9 M $222M
2017 Q4 128 17.3 M $211M
2017 Q3 122 19.1 M $262M
2017 Q2 137 19.9 M $307M
2017 Q1 120 17.0 M $313M
2016 Q4 102 13.8 M $129M
2016 Q3 82 11.6 M $96.9M
2016 Q2 70 13.3 M $120M
2016 Q1 93 16.3 M $102M
2015 Q4 96 20.2 M $341M
2015 Q3 92 18.6 M $271M
2015 Q2 75 12.1 M $147M
2015 Q1 60 11.1 M $112M
2014 Q4 56 10.4 M $104M
2014 Q3 56 9.72 M $81.5M
2014 Q2 49 8.77 M $149M
2014 Q1 42 8.62 M $160M